Advertisement

Topics

Ex-Inotek Exec to Lead Flex Pharma as Westphal Steps Down

07:25 EDT 6 Jun 2017 | Xconomy

Christoph Westphal has stepped down as the CEO of Flex Pharma (NASDAQ: FLKS). William McVicar, a former Inotek Pharmaceuticals executive and currently Flex’s president of R&D, will serve as Flex’s interim CEO. Westphal, who helped form the company, will remain chairman.

Original Article: Ex-Inotek Exec to Lead Flex Pharma as Westphal Steps Down

NEXT ARTICLE

More From BioPortfolio on "Ex-Inotek Exec to Lead Flex Pharma as Westphal Steps Down"

Quick Search
Advertisement